Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

被引：0

作者：

Sung Gwe Ahn

Yoon Jin Cha

Soon June Bae

Chanik Yoon

Hak Woo Lee

Joon Jeong

机构：

[1] Yonsei University College of Medicine,Department of Surgery, Gangnam Severance Hospital

[2] Yonsei University College of Medicine,Department of Pathology, Gangnam Severance Hospital

来源：

BMC Cancer | / 18卷

关键词：

Tumor-infiltrating lymphocytes; 21-gene recurrence score; Breast cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
Ahn, Sung Gwe
Cha, Yoon Jin
Bae, Soon June
Yoon, Chanik
Lee, Hak Woo
Jeong, Joon
BMC CANCER, 2018, 18
[2] Comparisons of tumor-infiltrating lymphocytes and 21-gene recurrence score in ER-positive/ HER2-negative breast cancer
Ahn, S. G.
Cha, Y. J.
Yoon, C.
Bae, S. J.
Kim, J.
Jeong, J.
ANNALS OF ONCOLOGY, 2017, 28
[3] Survival outcomes according to tumor-infiltrating lymphocytes and 21-gene recurrence score in ER+HER2-breast cancer
Ahn, S. G.
Ho, B. Seung
Minji, L.
Moon, S.
Kook, Y.
Bae, S. J.
Lee, S. B.
Jeong, J.
ANNALS OF ONCOLOGY, 2024, 35 : S338 - S339
[4] Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
Poorvu, Philip D.
Gelber, Shari, I
Rosenberg, Shoshana M.
Ruddy, Kathryn J.
Tamimi, Rulla M.
Collins, Laura C.
Peppercorn, Jeffrey
Schapira, Lidia
Borges, Virginia F.
Come, Steven E.
Warner, Ellen
Jakubowski, Debbie M.
Russell, Christy
Winer, Eric P.
Partridge, Ann H.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 725 - +
[5] Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
Bernhard C. Pestalozzi
Christoph Tausch
Konstantin J. Dedes
Christoph Rochlitz
Stefan Zimmermann
Roger von Moos
Ralph Winterhalder
Thomas Ruhstaller
Andreas Mueller
Katharina Buser
Markus Borner
Urban Novak
Catrina Uhlmann Nussbaum
Bettina Seifert
Martin Bigler
Vincent Bize
Simona Berardi Vilei
Christoph Rageth
Stefan Aebi
BMC Cancer, 17
[6] Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
Ahn, Sung Gwe
Bae, Soong June
Yoon, Changik
Cha, Yoon Jin
Lee, Hak Woo
Lee, Seung Ah
Jeong, Joon
PLOS ONE, 2017, 12 (11):
[7] Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
Pestalozzi, Bernhard C.
Tausch, Christoph
Dedes, Konstantin J.
Rochlitz, Christoph
Zimmermann, Stefan
von Moos, Roger
Winterhalder, Ralph
Ruhstaller, Thomas
Mueller, Andreas
Buser, Katharina
Borner, Markus
Novak, Urban
Nussbaum, Catrina Uhlmann
Seifert, Bettina
Bigler, Martin
Bize, Vincent
Vilei, Simona Berardi
Rageth, Christoph
Aebi, Stefan
BMC CANCER, 2017, 17
[8] Chemosensitivity of ER-positive/HER2-negative breast cancers with higher 21-gene recurrence score (≥ 26): a study based on in vitro chemoresponse assay
Ahn, S. G.
Lee, H. W.
Lim, J. W.
Baek, S. H.
Bae, S. J.
Yoon, C.
Cha, Y. J.
Jeong, J.
BREAST, 2017, 32 : S88 - S88
[9] Tumor-infiltrating lymphocytes (TILs) and 21-gene recurrence score in 1,883 patients with ER+/HER2-breast cancer
Ahn, Sung Gwe
Jang, Ji Soo
Kook, Yoonwon
Baek, Seung Ho
Lee, Sae Byul
Bae, Soong June
Jeong, Joon
CANCER RESEARCH, 2023, 83 (05)
[10] 21-gene recurrence score assay as a predictor of pathological response in neoadjuvant chemotherapy administration for ER-positive/HER2-negative early-stage breast cancer.
Morales Murillo, Serafin
Gasol Cudos, Ariadna
Rodriguez, Alvaro
Canosa Morales, Carles
Mele Olive, Jordi
Vilardell, Felip
Sanchez Guzman, Douglas
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →